Additional file 1: of PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Table S1. Genes Confirmed to Induce BRCAness in Prostate Non- and Cancerous Cell Lines. (DOC 51 kb)